9489-9002 Québec inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- April 28, 2025 – March 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q1-1030052
Published purpose
This project involves integrating tumour-specific antibodies into targeted cancer therapies by conjugating them with a chemotoxic agent. These antibody-drug conjugates will then be evaluated for their ability to kill tumour cells.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions